(Press-News.org) July 16, 2012 – (BRONX, NY) – Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have found that people with a form of mild cognitive impairment (MCI), a risk factor for developing Alzheimer's disease, have twice the risk of dying compared with cognitively normal people. Those with dementia have three times the risk. The findings are being presented at the Alzheimer's Association International Conference in Vancouver this week.
Amnestic MCI is a condition in which people have memory problems more severe than normal for their age and education, but not serious enough to affect daily life. (Another form of MCI, nonamnestic MCI, is characterized by impaired thinking skills other than memory, such as trouble planning and organizing or poor judgment.) According to the Alzheimer's Association, long-term studies suggest that 10 to 20 percent of people aged 65 and older may have MCI.
Einstein researchers studied 733 individuals enrolled in the Einstein Aging Study. The participants were at least 70-years-old and lived in The Bronx. At the start of the study, each had a cognitive evaluation for baseline and at least one annual follow-up visit. They were also tested for the APOE-4 gene variant, which is linked to increased risk for Alzheimer's. Participants were followed for an average of five years (up to a high of 16 years).
Study investigators found that participants with amnestic MCI had more than two times (2.17) greater risk of death. Nonamnestic MCI did not appear to increase mortality risk. The risk of death among participants with dementia was more than three times greater (3.26) than that of those who were cognitively normal. Researchers also found that having the APOE-4 gene variant, a greater number of co-morbidities, and severe depression were also related to higher risk of mortality.
"While there is no treatment for MCI, dementia or Alzheimer's, these findings support the benefits of early detection and monitoring of cognitive impairment in order to prolong life," said Richard Lipton, M.D., the senior author of the study and director of the Einstein Aging Study. Dr. Lipton is also the Edwin S. Lowe Chair in Neurology at Einstein and professor and vice chair of the Saul R. Korey Department of Neurology at Einstein and Montefiore Medical Center, the University Hospital for Einstein.
The Einstein Aging Study examines both normal brain aging and the special challenges of Alzheimer's disease and other dementias. Since its initial funding 30 years ago by the National Institute on Aging (AG003949), part of the National Institutes of Health, its investigators have contributed to the understanding of brain aging by tracking over 2,000 Bronx County residents in order to facilitate earlier diagnosis, prevention and treatment of Alzheimer's disease.
INFORMATION:
Albert Einstein College of Medicine
Albert Einstein College of Medicine of Yeshiva University is one of the nation's premier centers for research, medical education and clinical investigation. In 2011, Einstein received nearly $170 million in awards from the NIH for major research centers at Einstein in diabetes, cancer, liver disease, and AIDS, as well as other areas. Through its affiliation with Montefiore Medical Center, the University Hospital for Einstein, and six other hospital systems, the College of Medicine runs one of the largest post-graduate medical training programs in the United States, offering 155 residency programs to more than 2,200 physicians in training. For more information, please visit www.einstein.yu.edu and follow us on Twitter @EinsteinMed.
Montefiore Medical Center
As the University Hospital for Albert Einstein College of Medicine, Montefiore is a premier academic medical center nationally renowned for its clinical excellence, scientific discovery and commitment to its community. Montefiore is consistently recognized among the top hospitals nationally by U.S. News & World Report, and excels at educating tomorrow's healthcare professionals in superior clinical and humanistic care. Linked by advanced technology, Montefiore is a comprehensive and integrated health system that derives its inspiration for excellence from its patients and community. For more information, please visit www.montefiore.org and www.montekids.org and follow us on Twitter @MontefioreNews.
END
A new study from the European Centre for Environment & Human Health, Peninsula College of Medicine and Dentistry, University of Exeter, has revealed that people living near the coast tend to have better health than those living inland.
Researchers from the Centre used data from the UK's census to examine how health varied across the country, finding that people were more likely to have good health the closer they live to the sea. The analysis also showed that the link between living near the coast and good health was strongest in the most economically deprived communities.
The ...
VIDEO:
This video shows relative movement paths of 224 radio-tagged palm seeds handled by rodents on Barro Colorado Island, Panama. Colored dots mark locations of 129 seeds that were found eaten...
Click here for more information.
Big seeds produced by many tropical trees were probably once ingested and then defecated whole by huge mammals called gomphotheres that dispersed the seeds over large distances. But gomphotheres were probably hunted to extinction more than 10,000 ...
ONCOLOGY
A new target in acute myeloid leukemia | Back to top
Acute myeloid leukemia, a common leukemia in adults, is characterized by aberrant proliferation of cancerous bone marrow cells. Activating mutations in a protein receptor known as FLT3 receptor are among the most prevalent mutations observed in acute myeloid leukemias. FLT3 mutants are thought to activate several signaling pathways that contribute to cancer development. Dr. Daniel Tenen and colleagues from Harvard University in Boston discovered a new pathway activated by FLT3 mutation. Their results show ...
Acute myeloid leukemia, a common leukemia in adults, is characterized by aberrant proliferation of cancerous bone marrow cells. Activating mutations in a protein receptor known as FLT3 receptor are among the most prevalent mutations observed in acute myeloid leukemias. FLT3 mutants are thought to activate several signaling pathways that contribute to cancer development. Dr. Daniel Tenen and colleagues from Harvard University in Boston discovered a new pathway activated by FLT3 mutation. Their results show that cyclin dependent kinase 1 (CDK1), a critical regulator of cell ...
Ticagrelor, a blood-thinning drug approved by the FDA in 2011, should be considered along with older blood thinners clopidogrel and prasugrel for treating patients who are experiencing chest pain or some heart attacks, according to joint updated guidelines issued by the American Heart Association (AHA) Task Force on Practice Guidelines and the American College of Cardiology (ACCF) Foundation.
The "focused update" on unstable angina (chest pain) or a specific kind of heart attack known as non-ST-elevation myocardial infarction (NSTEMI) is published in Circulation: Journal ...
CORVALLIS, Ore. – A new study suggests that higher blood pressure is associated with lower mortality in extremely frail, elderly adults.
The study, published today in the Journal of the American Medical Association's (JAMA) Archives of Internal Medicine, looked at a nationally representative group of 2,340 adults ages 65 and older. The researchers found that lower blood pressure protected healthier, robust older adults but the same may not be true for their more frail counterparts.
Lead author Michelle Odden, a public health epidemiologist at Oregon State University, ...
CHICAGO – A study suggests that safety-net hospitals (SNHs), which typically care for poor patients, performed more poorly than other hospitals on nearly every measure of patient experience and that could have financial consequences as hospital payments are connected to performance, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.
Value-based purchasing (VBP), a program run by the Centers for Medicare and Medicaid Services (CMS), now ties part of each hospital's payments to its performance on a set of quality measures. ...
COLUMBIA, Mo. – Currently, large doses of chemotherapy are required when treating certain forms of cancer, resulting in toxic side effects. The chemicals enter the body and work to destroy or shrink the tumor, but also harm vital organs and drastically affect bodily functions. Now, University of Missouri scientists have found a more efficient way of targeting prostate tumors by using gold nanoparticles and a compound found in tea leaves. This new treatment would require doses that are thousands of times smaller than chemotherapy and do not travel through the body inflicting ...
An innovative, high-tech "smart village" built in Malaysia provides a potential global template for addressing rural poverty in a sustainable environment, say international experts meeting in California's Silicon Valley.
Rimbunan Kaseh, a model community built north-east of Kuala Lumpur, consists of 100 affordable homes, high-tech educational, training and recreational facilities, and a creative, closed-loop agricultural system designed to provide both food and supplementary income for villagers.
Malaysian Dato' Tan Say Jim detailed the project Monday at a special meeting ...
CHICAGO – A study suggests bariatric surgery to treat obesity was not associated with reduced health care expenditures three years after the procedure in a group of predominantly older men, according to a report in the July issue of Archives of Surgery, a JAMA Network publication.
Bariatric surgery is the most effective way to induce weight loss in the severely obese. As demand for the procedure has increased, the numbers of nonwhite, older and male patients with a greater prevalence of obesity-related diseases have increased, although the related health care expenditure ...
